臺北醫學大學臺北心臟醫學研究中心

Medicine & Life Sciences

1. Action Potentials 18%
2. Angiotensin II 20%
3. Antihypertensive Agents 9%
4. Antioxidants 21%
5. Apoptosis 14%
6. Atherosclerosis 13%
7. Atrial Fibrillation 100%
8. Atrial Flutter 15%
9. Atrial Remodeling 12%
10. Blood Pressure 25%
11. Blood Vessels 14%
12. Calcium 37%
13. Cardiac Arrhythmias 30%
14. Cardiac Myocytes 57%
15. Cardiology 9%
16. Cardiovascular Diseases 19%
17. Catheter Ablation 38%
18. Chronic Obstructive Pulmonary Disease 10%
19. Chronic Renal Insufficiency 16%
20. Cohort Studies 25%
21. Collagen 9%
22. Computed Tomography Angiography 9%
23. Confidence Intervals 14%
24. Coronary Artery Disease 16%
25. Coronary Vessels 27%
26. Diabetes Mellitus 12%
27. Down-Regulation 12%
28. Elderly 13%
29. Electrocardiography 15%
30. Electrophysiology 14%
31. Endothelial Cells 30%
32. Endothelial Progenitor Cells 24%
33. Endothelin-1 29%
34. Exercise 9%
35. Extracellular Signal-Regulated MAP Kinases 11%
36. Fibroblasts 18%
37. Fibrosis 10%
38. Gene Expression 13%
39. Glucose 10%
40. Glyburide 10%
41. Heart 20%
42. Heart Atria 30%
43. Heart Failure 41%
44. Heme Oxygenase-1 11%
45. Histone Deacetylases 13%
46. Homeostasis 16%
47. Hospitalization 11%
48. Human Influenza 16%
49. Human Umbilical Vein Endothelial Cells 12%
50. Hydroxymethylglutaryl-CoA Reductase Inhibitors 17%
51. Hypertension 22%
52. Hypertrophy 14%
53. In Vitro Techniques 10%
54. Inbred SHR Rats 11%
55. Incidence 11%
56. Infarction 11%
57. Inflammation 17%
58. KATP Channels 11%
59. Kidney 14%
60. LCZ 696 9%
61. Lipids 11%
62. Lithium 10%
63. Messenger RNA 9%
64. Mortality 15%
65. Muscle Cells 13%
66. Myocardial Infarction 23%
67. Neoplasms 13%
68. Nicorandil 17%
69. Nitric Oxide 12%
70. Nitric Oxide Synthase Type III 10%
71. Oxidative Stress 17%
72. oxidized low density lipoprotein 9%
73. p38 Mitogen-Activated Protein Kinases 10%
74. Peroxisome Proliferator-Activated Receptors 13%
75. Pharmaceutical Preparations 11%
76. Phosphorylation 14%
77. Population 23%
78. Pravastatin 13%
79. Proteins 16%
80. Pulmonary Veins 84%
81. Rabbits 18%
82. Reactive Oxygen Species 23%
83. Sinoatrial Node 13%
84. Sitagliptin Phosphate 10%
85. Smooth Muscle Myocytes 17%
86. stevioside 12%
87. Stroke 15%
88. Superoxide Dismutase 13%
89. Tachycardia 10%
90. Taiwan 42%
91. tanshinone 9%
92. Therapeutics 23%
93. trilinolein 24%
94. Type 2 Diabetes Mellitus 11%
95. urotensin II 10%
96. Vaccination 16%
97. Ventricular Remodeling 11%
98. Ventricular Tachycardia 11%
99. Western Blotting 10%
100. Wounds and Injuries 9%